2019
DOI: 10.1016/j.arteri.2018.06.007
|View full text |Cite
|
Sign up to set email alerts
|

Riesgo cardiovascular residual de origen lipídico. Componentes y aspectos fisiopatológicos

Abstract: ARTERI-457; No. of Pages 14 2 A. Hernández-Mijares et al. los fármacos dirigidos al descenso de triglicéridos y cHDL; el fenofibrato parece tener eficacia en situaciones de dislipidemia aterogénica.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 111 publications
0
1
0
Order By: Relevance
“…SdLDLs, containing less cholesterol, will easily enter and be trapped compared to the larger LDLs, which contain more cholesterol. On the other hand, the larger LDLs carry more cholesterol that will be released in the injured artery wall, causing more tissue damage 23 . Therefore, both large and small LDLs contribute to atherogenesis but mechanisms may differ between LDL classes.…”
Section: Vldl Accumulation Promotes Pro-atherogenic Changes In Other Plasma Lipoproteins (High-density Lipoproteins [Hdl] and Ldl) By Accmentioning
confidence: 99%
“…SdLDLs, containing less cholesterol, will easily enter and be trapped compared to the larger LDLs, which contain more cholesterol. On the other hand, the larger LDLs carry more cholesterol that will be released in the injured artery wall, causing more tissue damage 23 . Therefore, both large and small LDLs contribute to atherogenesis but mechanisms may differ between LDL classes.…”
Section: Vldl Accumulation Promotes Pro-atherogenic Changes In Other Plasma Lipoproteins (High-density Lipoproteins [Hdl] and Ldl) By Accmentioning
confidence: 99%